QPBE
ALNY icon

Quintet Private Bank (Europe)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quintet Private Bank (Europe)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,217
Closed -$231K – 245
2023
Q2 		$231K Sell
1,217
-1,303
-52% -$258K 0.01% 143
2023
Q1 		$505K Buy
+2,520
New +$530K 0.03% 107
2022
Q2 		$231K Buy
+1,217
New +$173K 0.01% 143

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Quintet Private Bank (Europe)'s ALNY Position: Q3 2023 in Review

Quintet Private Bank (Europe) sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2023, closing a stake of 1,217 shares — an estimated $231K sold.

Quintet Private Bank (Europe) first reported a position in ALNY in Q2 2022 and held it in 3 quarters. The position peaked at $505K in Q1 2023. 453 funds tracked by Wall St. Rank hold ALNY as of Q3 2023.

  • Quintet Private Bank (Europe) reported no remaining Alnylam Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 1,217 Alnylam Pharmaceuticals shares in Q3 2023, an estimated $231K.
  • Quintet Private Bank (Europe) first reported a position in Alnylam Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Quintet Private Bank (Europe)'s Alnylam Pharmaceuticals position peaked at $505K in Q1 2023.
  • 453 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2023.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2023, filed 13 Nov 2023.